Becker's ASC Review

July_August_2019_ASC

Issue link: https://beckershealthcare.uberflip.com/i/1156517

Contents of this Issue

Navigation

Page 24 of 71

The iFuse Implant System ® is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. The iFuse Implant System is also intended for sacroiliac fusion to augment immobilization and stabilization of the sacroiliac joint in skeletally mature patients undergoing sacropelvic fixation as a part of a lumbar or thoracolumbar fusion. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. Rx Only. For information about the risks, visit www.si-bone.com/risks SI-BONE and iFuse Implant System are registered trademarks of SI-BONE, Inc. ©2019 SI-BONE, Inc. All rights reserved. Patents www.sibone.com 10433.061019 Sit to Stand Sitting IF YOUR PATIENTS FEEL PAIN WHEN… Stepping Up it may be from a dysfunctional SI joint Find out more at si-bone.com/facility

Articles in this issue

Links on this page

view archives of Becker's ASC Review - July_August_2019_ASC